developability assessment is a crucial part of the preclinical development process.
Successful prediction of such properties and bioassay results from calculated in silico
features has potential to reduce the time and cost of delivering clinical-grade material to
patients, but nevertheless has remained an ongoing challenge to the field. Here, we
demonstrate an automated and flexible machine learning workflow designed to compare …